BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 25666998)

  • 21. Optimizing preoperative haemoglobin in major orthopaedic surgery using intravenous iron with or without erythropoietin. An epidemiologic study.
    Basora M; Colomina MJ; Tio M; Mora L; Sánchez-Etayo G; Salazar F; Ciércoles E; Paños M; Guerrero E; Berge R
    Rev Esp Anestesiol Reanim; 2015; 62(6):313-21. PubMed ID: 25698609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of intravenous ferric carboxymaltose on red cell distribution width: a subanalysis of the FAIR-HF study.
    Van Craenenbroeck EM; Conraads VM; Greenlaw N; Gaudesius G; Mori C; Ponikowski P; Anker SD
    Eur J Heart Fail; 2013 Jul; 15(7):756-62. PubMed ID: 23639779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: a subanalysis of the FAIR-HF study.
    Comin-Colet J; Lainscak M; Dickstein K; Filippatos GS; Johnson P; Lüscher TF; Mori C; Willenheimer R; Ponikowski P; Anker SD
    Eur Heart J; 2013 Jan; 34(1):30-8. PubMed ID: 22297124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Iron deficiency: an emerging therapeutic target in heart failure.
    Cohen-Solal A; Leclercq C; Deray G; Lasocki S; Zambrowski JJ; Mebazaa A; de Groote P; Damy T; Galinier M
    Heart; 2014 Sep; 100(18):1414-20. PubMed ID: 24957529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous iron in heart failure: beyond targeting anemia.
    Silverberg DS; Iaina A; Schwartz D; Wexler D
    Curr Heart Fail Rep; 2011 Mar; 8(1):14-21. PubMed ID: 21057903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and Efficacy of Intravenous Ferric Derisomaltose Compared to Iron Sucrose for Iron Deficiency Anemia in Patients with Chronic Kidney Disease With and Without Heart Failure.
    Ambrosy AP; von Haehling S; Kalra PR; Court E; Bhandari S; McDonagh T; Cleland JGF
    Am J Cardiol; 2021 Aug; 152():138-145. PubMed ID: 34162484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimal Serum Ferritin Levels for Iron Deficiency Anemia during Oral Iron Therapy (OIT) in Japanese Hemodialysis Patients with Minor Inflammation and Benefit of Intravenous Iron Therapy for OIT-Nonresponders.
    Takasawa K; Takaeda C; Wada T; Ueda N
    Nutrients; 2018 Mar; 10(4):. PubMed ID: 29596361
    [No Abstract]   [Full Text] [Related]  

  • 28. Influence of intravenous iron therapy on novel markers of iron deficiency.
    Chinnappa S; Bhandari S
    Int J Artif Organs; 2010 May; 33(5):297-301. PubMed ID: 20593351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NIMO-CKD-UK: a real-world, observational study of iron isomaltoside in patients with iron deficiency anaemia and chronic kidney disease.
    Kalra PA; Bhandari S; Spyridon M; Davison R; Lawman S; Mikhail A; Reaich D; Pritchard N; McCafferty K; Moore J
    BMC Nephrol; 2020 Dec; 21(1):539. PubMed ID: 33302891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic kidney disease: Serious adverse effects associated with IV iron in CKD.
    Allison SJ
    Nat Rev Nephrol; 2015 Sep; 11(9):506. PubMed ID: 26149838
    [No Abstract]   [Full Text] [Related]  

  • 31. The impact of intravenous ferric carboxymaltose on renal function: an analysis of the FAIR-HF study.
    Ponikowski P; Filippatos G; Colet JC; Willenheimer R; Dickstein K; Lüscher T; Gaudesius G; von Eisenhart Rothe B; Mori C; Greenlaw N; Ford I; Macdougall I; Anker SD;
    Eur J Heart Fail; 2015 Mar; 17(3):329-39. PubMed ID: 25683972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous iron therapy in patients with heart failure. A double-edged sword.
    Lippi G; Sanchis-Gomar F; Cervellin G
    Int J Cardiol; 2013 Oct; 168(5):4863. PubMed ID: 23890881
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of two iron gluconate treatment modalities in chronic hemodialysis patients: results of a randomized trial.
    Giordano A; Arrigo G; Lavarda F; Colasanti G; Petrini C
    J Nephrol; 2005; 18(2):181-7. PubMed ID: 15931646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of intravenous iron sucrose versus low-molecular-weight iron dextran in chronic kidney disease.
    Sinha S; Chiu DY; Peebles G; Kolakkat S; Lamerton E; Fenwick S; Kalra PA
    J Ren Care; 2009 Jun; 35(2):67-73. PubMed ID: 19432851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of Iron Isomaltoside on Skeletal Muscle Energetics in Patients With Chronic Heart Failure and Iron Deficiency.
    Charles-Edwards G; Amaral N; Sleigh A; Ayis S; Catibog N; McDonagh T; Monaghan M; Amin-Youssef G; Kemp GJ; Shah AM; Okonko DO
    Circulation; 2019 May; 139(21):2386-2398. PubMed ID: 30776909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute injury with intravenous iron and concerns regarding long-term safety.
    Bishu K; Agarwal R
    Clin J Am Soc Nephrol; 2006 Sep; 1 Suppl 1():S19-23. PubMed ID: 17699372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting Iron Deficiency Anemia in Heart Failure.
    Saraon T; Katz SD
    Prog Cardiovasc Dis; 2016; 58(4):407-15. PubMed ID: 26657161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease--a randomized, controlled, open-label, multicenter study.
    Schröder O; Mickisch O; Seidler U; de Weerth A; Dignass AU; Herfarth H; Reinshagen M; Schreiber S; Junge U; Schrott M; Stein J
    Am J Gastroenterol; 2005 Nov; 100(11):2503-9. PubMed ID: 16279906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of intravenous and oral iron administration on perioperative anaemia and transfusion requirements in patients undergoing elective cardiac surgery: a randomized clinical trial.
    Garrido-Martín P; Nassar-Mansur MI; de la Llana-Ducrós R; Virgos-Aller TM; Rodríguez Fortunez PM; Ávalos-Pinto R; Jimenez-Sosa A; Martínez-Sanz R
    Interact Cardiovasc Thorac Surg; 2012 Dec; 15(6):1013-8. PubMed ID: 22940889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protocol and Baseline Data of a Multicentre Prospective Double-Blinded Randomized Study of Intravenous Iron on Functional Status in Patients with Chronic Kidney Disease.
    Bhandari S; Allgar V; Lamplugh A; Macdougall IC; Kalra PA
    Am J Nephrol; 2020; 51(6):493-500. PubMed ID: 32348985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.